Acupuncture for palliative cancer pain management: systematic review
- PMID: 33441387
- PMCID: PMC8380897
- DOI: 10.1136/bmjspcare-2020-002638
Acupuncture for palliative cancer pain management: systematic review
Abstract
Background: Pain is one of the most common and problematic symptoms encountered by patients with cancer. Due to the multifactorial aetiology, pain management of these patients frequently requires multidisciplinary interventions including conventional support and specialty palliative care. Acupuncture has been identified as a possible adjunctive therapy for symptom management in cancer pain, and there is currently no systematic review focused solely on the evidence of acupuncture on cancer pain in palliative care.
Objective: To critically analyse currently available publications regarding the use of acupuncture for pain management among patients with cancer in palliative care settings.
Methods: Multiple academic databases were searched from inception to 29 October 2020. Randomised controlled trials involving acupuncture in palliative care for treatment of cancer-related pain were synthesised. Data were extracted by two independent reviewers, and methodological quality of each included study was assessed using the Oxford Centre for Evidence-Based Medicine (OCEBM) 2011 Levels of Evidence.
Results: Five studies (n=189) were included in this systematic review. Results indicated a favourable effect of acupuncture on pain relief in palliative care for patients with cancer. According to OCEBM 2011 Levels of Evidence, they were level 2 in one case (20%), level 3 in two cases (40%) and level 4 in the remaining (40%). Low-level evidence adversely affects the reliability of findings.
Conclusions: Acupuncture may be an effective and safe treatment associated with pain reduction in the palliative care of patients with cancer. Further high-quality, adequately powered studies are needed in the future.
Keywords: cancer; pain; supportive care.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea.Cochrane Database Syst Rev. 2002;2002(1):CD002123. doi: 10.1002/14651858.CD002123. Cochrane Database Syst Rev. 2002. PMID: 11869624 Free PMC article.
-
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Sep 15;9:CD006332. doi: 10.1002/14651858.CD006332.pub4. PMID: 29869799 Free PMC article. Updated.
-
Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. PMID: 15106156 Updated.
-
Interventions for palliative symptom control in COVID-19 patients.Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061. Cochrane Database Syst Rev. 2021. PMID: 34425019 Free PMC article.
Cited by
-
Inhibition of HDAC6 alleviates cancer‑induced bone pain by reducing the activation of NLRP3 inflammasome.Int J Mol Med. 2024 Jan;53(1):4. doi: 10.3892/ijmm.2023.5328. Epub 2023 Nov 24. Int J Mol Med. 2024. PMID: 37997785 Free PMC article.
-
Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias.Curr Issues Mol Biol. 2024 Sep 2;46(9):9721-9759. doi: 10.3390/cimb46090578. Curr Issues Mol Biol. 2024. PMID: 39329930 Free PMC article. Review.
-
Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials.BMJ Open. 2022 Sep 14;12(9):e060912. doi: 10.1136/bmjopen-2022-060912. BMJ Open. 2022. PMID: 36104141 Free PMC article.
-
Integrative Approaches to the Treatment of Cancer.Cancers (Basel). 2022 Nov 30;14(23):5933. doi: 10.3390/cancers14235933. Cancers (Basel). 2022. PMID: 36497414 Free PMC article. Review.
-
Evaluation of the Glymphatic System With Diffusion Tensor Imaging-Along the Perivascular Space in Cancer Pain.Front Neurosci. 2022 Mar 4;16:823701. doi: 10.3389/fnins.2022.823701. eCollection 2022. Front Neurosci. 2022. PMID: 35341017 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical